Semaglutide can be administered at a higher dose, which may contribute to its increased effectiveness in reducing appetite and caloric intake
While large clinical trials in type 1 diabetes showed that metformin had little effect on A1C and body weight, other research has shown that the same group does benefit from metformin, particularly for addressing insulin resistance
While initially approved for type 2 diabetes management, this medication has shown clinically relevant weight reduction benefits in individuals without diabetes
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, et al Liraglutide and cardiovascular outcomes in type 2 diabetes N Engl J Med 2016 375 31122 5
This step-by-step approach allows clients to tolerate the medication more comfortably while still benefiting from its appetite-regulating effects